BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2751268)

  • 61. [Clinical conference: Prognostic importance of medullary fibrosis in chronic myeloid leukemia].
    Bryon PA; Fiere D; Revol L
    Nouv Rev Fr Hematol; 1975; 15(2):303-4. PubMed ID: 126443
    [No Abstract]   [Full Text] [Related]  

  • 62. Prognostic factors in idiopathic myelofibrosis: a simple scoring system with prognostic significance.
    Hasselbalch H; Jensen BA
    Eur J Haematol; 1990 Mar; 44(3):172-8. PubMed ID: 2328790
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Anatomo-pathologic forms of lymphoid and lymphoreticular fibrosis of the bone marrow].
    Duhamel G; Stachowiak J
    Ann Med Interne (Paris); 1976 Apr; 127(4):287-94. PubMed ID: 1015721
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Prognostic factors in myelofibrosis.
    Manoharan A; Smart RC; Pitney WR
    Pathology; 1982 Oct; 14(4):455-61. PubMed ID: 7155637
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Current perspective in agnogenic myeloid metaplasia.
    Tefferi A; Silverstein MN
    Leuk Lymphoma; 1996 Sep; 22 Suppl 1():169-71. PubMed ID: 8951788
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Myelofibrosis in chronic granulocytic leukaemia: clinicopathologic correlations and prognostic significance.
    Lazzarino M; Morra E; Castello A; Inverardi D; Coci A; Pagnucco G; Magrini U; Zei G; Bernasconi C
    Br J Haematol; 1986 Oct; 64(2):227-40. PubMed ID: 3465364
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Correlation of radiologic, histologic, and clinical findings in agnogenic myeloid metaplasia.
    Pettigrew JD; Ward HP
    Radiology; 1969 Sep; 93(3):541-8. PubMed ID: 5822732
    [No Abstract]   [Full Text] [Related]  

  • 68. Bone marrow fibre production in myelofibrosis: a quantitative study.
    Bentley SA; Herman CJ
    Br J Haematol; 1979 May; 42(1):51-9. PubMed ID: 465360
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Erythropoiesis in primary (idiopathic) osteomyelofibrosis: quantification, PCNA-reactivity, and prognostic impact.
    Thiele J; Windecker R; Kvasnicka HM; Titius BR; Zankovich R; Fischer R
    Am J Hematol; 1994 May; 46(1):36-42. PubMed ID: 7910431
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Myelofibrosis with myeloid metaplasia: pathophysiologic implications of the correlation between bone marrow changes and progression of splenomegaly.
    Wolf BC; Neiman RS
    Blood; 1985 Apr; 65(4):803-9. PubMed ID: 3978228
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Prognostic impact of apoptosis and proliferation in idiopathic (primary) myelofibrosis.
    Kvasnicka HM; Thiele J; Regn C; Zankovich R; Diehl V; Fischer R
    Ann Hematol; 1999 Feb; 78(2):65-72. PubMed ID: 10089020
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Histo-immunology of myelofibrosis: a study of 100 cases.
    Barge J; Slabodsky-Brousse N; Bernard JF
    Biomedicine; 1978 Apr; 29(2):73-5. PubMed ID: 352422
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Agnogenic myeloid metaplasia, portal hypertension, and sinusoidal abnormalities.
    Roux D; Merlio JP; Quinton A; Lamouliatte H; Balabaud C; Bioulac-Sage P
    Gastroenterology; 1987 Apr; 92(4):1067-72. PubMed ID: 3493936
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Liver involvement at diagnosis of primary myelofibrosis: a clinicopathological study of twenty-two cases.
    Pereira A; Bruguera M; Cervantes F; Rozman C
    Eur J Haematol; 1988 Apr; 40(4):355-61. PubMed ID: 3366226
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Resident bone marrow macrophages in idiopathic (primary) myelofibrosis (IMF): a histochemical and morphometric study on sequential trephine biopsies.
    Thiele J; Kvasnicka HM; Boeltken B
    Leuk Res; 1999 Nov; 23(11):983-5. PubMed ID: 10576501
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Myelofibrosis with myeloid metaplasia: diagnostic definition and prognostic classification for clinical studies and treatment guidelines.
    Barosi G
    J Clin Oncol; 1999 Sep; 17(9):2954-70. PubMed ID: 10561375
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Spontaneous hematologic remission in agnogenic myeloid metaplasia.
    Shreiner DP
    Am J Med; 1976 Jun; 60(7):1014-8. PubMed ID: 937347
    [TBL] [Abstract][Full Text] [Related]  

  • 78. 'Classic' and 'acute' myelofibrosis. A retrospective study.
    Rojer RA; Mulder NH; Nieweg HO
    Acta Haematol; 1978; 60(2):108-16. PubMed ID: 98950
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Clinicopathological features of seven cases of canine myelofibrosis and the possible relationship between the histological findings and prognosis.
    Villiers EJ; Dunn JK
    Vet Rec; 1999 Aug; 145(8):222-8. PubMed ID: 10499855
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Primary myelofibrosis: a detailed statistical analysis of the clinicopathological variables influencing survival.
    Rupoli S; Da Lio L; Sisti S; Campanati G; Salvi A; Brianzoni MF; D'Amico S; Cinciripini A; Leoni P
    Ann Hematol; 1994 Apr; 68(4):205-12. PubMed ID: 8003563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.